Proteins and Peptides
1 September 2015
MediWound Completes Enrollment in Second Phase 2 Clinical Trial of EscharEx(R) to Treat Chronic and Other Hard-to-Heal Wounds1 September 2015
RCT Demonstrates a Hundred-Fold Improvement in Penetration of Solid Tumors Using Therapeutic ABDURINS Compared to Antibodies26 August 2015
Novo Nordisk to initiate phase 3a development of oral semaglutide, a once-daily oral GLP-1 analogue20 August 2015
U.S. FDA Accepts BOTOX® (onabotulinumtoxinA) Resubmission for the Treatment of Lower Limb Spasticity in Adults19 August 2015
Intarcia Announces New Top-Line Phase 3 Results For Investigational Therapy ITCA 650 In Type 2 Diabetes18 August 2015
Chiasma Announces FDA Acceptance For Filing of New Drug Application for Octreotide Capsules in Acromegaly18 August 2015
BioLineRx Announces Initiation of Phase 2b Trial for Novel AML Consolidation Treatment18 August 2015
Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of ALPROLIX for the Treatment of Hemophilia BNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports